Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response ; volume:23 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-6 ; date:12.2024
Molecular cancer ; 23, Heft 1 (11.10.2024), 1-6, 12.2024
- Creator
-
Lim, Su Yin
Silva, Ines Pires da
Adegoke, Nurudeen A.
Lo, Serigne N.
Menzies, Alexander M.
Carlino, Matteo S.
Scolyer, Richard A.
Long, Georgina V.
Lee, Jenny H.
Rizos, Helen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-02146-0
- URN
-
urn:nbn:de:101:1-2412302102548.771205871084
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lim, Su Yin
- Silva, Ines Pires da
- Adegoke, Nurudeen A.
- Lo, Serigne N.
- Menzies, Alexander M.
- Carlino, Matteo S.
- Scolyer, Richard A.
- Long, Georgina V.
- Lee, Jenny H.
- Rizos, Helen
- SpringerLink (Online service)
Other Objects (12)
Imaging of tumour response to immunotherapy
Predicting cancer type from tumour DNA signatures
Unravelling mutational signatures with plasma circulating tumour DNA
HNSCC: tumour antigens and their targeting by immunotherapy
Blood matters: the hematological signatures of Coronavirus infection
APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
A role for immunotherapy: preventing macrophage anergy in the tumour environment
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Imaging of tumour response to immunotherapy
Predicting cancer type from tumour DNA signatures
Unravelling mutational signatures with plasma circulating tumour DNA
HNSCC: tumour antigens and their targeting by immunotherapy
Blood matters: the hematological signatures of Coronavirus infection
APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
A role for immunotherapy: preventing macrophage anergy in the tumour environment
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Imaging of tumour response to immunotherapy
Predicting cancer type from tumour DNA signatures
Unravelling mutational signatures with plasma circulating tumour DNA
HNSCC: tumour antigens and their targeting by immunotherapy
Blood matters: the hematological signatures of Coronavirus infection
APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
A role for immunotherapy: preventing macrophage anergy in the tumour environment
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences